New hope for aggressive blood cancer patients ineligible for standard chemo
NCT ID NCT07044687
Summary
This study is testing a combination of two drugs, venetoclax and azacitidine, for adults in India newly diagnosed with an aggressive blood cancer called acute myeloid leukemia (AML) who are not eligible for standard intensive chemotherapy. The main goals are to see how well the treatment controls the disease and to monitor side effects. About 100 participants will take oral venetoclax daily and receive azacitidine injections for up to 29 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
All India Institute Of Medical Sciences - Bhubaneswar /ID# 274879
RECRUITINGBhubaneswar, Odisha, 751019, India
-
All India Institute Of Medical Sciences - New Delhi /ID# 268357
RECRUITINGNew Delhi, National Capital Territory of Delhi, 110029, India
-
Apollo Cancer Centre /ID# 268780
RECRUITINGChennai, Tamil Nadu, 600035, India
-
Basavatarakam Indo American Cancer Hospital & Research Institute /ID# 268692
RECRUITINGHyderabad, Telangana, 500034, India
-
Cancer Institute (Wia) /ID# 268695
RECRUITINGChennai, Tamil Nadu, 600036, India
-
Fortis Memorial Research Institute /ID# 268697
RECRUITINGGurgaon, Haryana, 122002, India
-
LMMF's Deenanath Mangeshkar Hospital & Research Center /ID# 268781
RECRUITINGPune, Maharashtra, 411004, India
-
Mazumdar Shaw Medical Center /ID# 270677
RECRUITINGBengaluru, Karnataka, 560099, India
-
Rajiv Gandhi Cancer Institute And Research Centre /ID# 268293
RECRUITINGNew Delhi, National Capital Territory of Delhi, 110085, India
-
Regional Cancer Centre /ID# 268785
RECRUITINGThiruvananthapuram, Kerala, 695011, India
-
Sahyadri Super Speciality Hospital /ID# 272074
RECRUITINGPune, Maharashtra, 411004, India
Conditions
Explore the condition pages connected to this study.